Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.
Related Posts
Dexcom’s over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels
Dexcom is bringing generative AI to Stelo users, starting with weekly personalized reports about their glucose
Powell says he would not resign as Fed chief if Trump asked for his resignation
When asked whether he would resign if asked by Trump, the Fed chair simply said: “No.”
Fed Governor Bowman says December interest rate cut should be the last
Bowman said Thursday she supported the recent interest rate cuts but doesn’t see the need to go any further.